FDA Inspection 1000900 — Rajeev Agarwal, M.D.
The FDA completed an inspection of Rajeev Agarwal, M.D. on Jan 5, 2017 in Uttar Pradesh. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Uttar Pradesh (India)
Additional Details
Clinical Investigator (CI)